Pluri Inc. Retained Earnings
Pluri Inc. (PLUR) had Retained Earnings of -$466.88 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-10
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$466.88M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$461.00M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$455.45M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$448.90M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$466.88M 10-K · filed 2026-09-10 |
| 2026-03-31 | -$461.00M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$455.45M 10-Q · filed 2026-02-12 |
| 2025-09-30 | -$448.90M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$443.06M 10-K · filed 2026-09-10 |
| 2025-03-31 | -$435.46M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$429.31M 10-Q · filed 2025-02-11 |
| 2024-09-30 | -$426.35M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$420.47M 10-K · filed 2025-09-17 |
| 2024-03-31 | -$414.74M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$409.45M 10-Q · filed 2024-02-12 |
| 2023-09-30 | -$404.55M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$399.58M 10-K · filed 2024-09-18 |
| 2023-03-31 | -$393.13M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$385.50M 10-Q · filed 2023-02-13 |
| 2022-09-30 | -$377.38M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$371.26M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$362.26M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$352.39M 10-Q · filed 2022-02-07 |
| 2021-09-30 | -$341.45M 10-Q · filed 2021-11-08 |
| 2021-06-30 | -$330.02M 10-K · filed 2022-09-21 |
| 2021-03-31 | -$315.45M 10-Q · filed 2021-05-06 |
| 2020-12-31 | -$301.20M 10-Q · filed 2021-02-08 |
| 2020-09-30 | -$288.64M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$280.16M 10-K · filed 2021-09-13 |
| 2020-03-31 | -$272.02M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$264.51M 10-Q · filed 2020-02-06 |
| 2019-09-30 | -$258.14M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$251.00M 10-K · filed 2020-09-10 |
| 2019-03-31 | -$243.24M 10-Q · filed 2019-05-06 |
| 2018-12-31 | -$233.17M 10-Q · filed 2019-02-06 |
| 2018-09-30 | -$224.48M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$215.70M 10-K · filed 2019-09-12 |
| 2018-03-31 | -$206.72M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$205.19M 10-Q · filed 2018-02-06 |
| 2017-09-30 | -$196.96M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$189.57M 10-K · filed 2018-09-12 |
| 2017-03-31 | -$182.56M 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$174.69M 10-Q · filed 2017-02-08 |
| 2016-09-30 | -$168.08M 10-Q · filed 2016-11-07 |
| 2016-06-30 | -$161.76M 10-K · filed 2017-09-07 |
| 2016-03-31 | -$155.55M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$148.35M 10-Q · filed 2016-02-08 |
| 2015-09-30 | -$144.39M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$138.51M 10-K · filed 2016-09-07 |
| 2015-03-31 | -$133.22M 10-Q · filed 2015-05-06 |
| 2014-12-31 | -$125.99M 10-Q · filed 2015-02-05 |
| 2014-09-30 | -$119.75M 10-Q · filed 2014-11-06 |
| 2014-06-30 | -$113.83M 10-K · filed 2015-09-09 |
| 2014-03-31 | -$107.64M 10-Q · filed 2014-05-08 |
| 2013-12-31 | -$98.36M 10-Q · filed 2014-02-05 |
| 2013-09-30 | -$91.66M 10-Q · filed 2013-11-05 |
| 2013-06-30 | -$86.90M 10-K · filed 2014-09-11 |
| 2013-03-31 | -$79.91M 10-Q · filed 2013-05-08 |
| 2012-12-31 | -$74.23K 10-Q · filed 2013-01-31 |
| 2012-09-30 | -$69.74M 10-Q · filed 2012-11-06 |
| 2012-06-30 | -$65.75M 10-K · filed 2013-09-11 |
| 2012-03-31 | -$61.61M 10-Q · filed 2012-05-08 |
| 2011-12-31 | -$57.44M 10-Q · filed 2012-02-09 |
| 2011-09-30 | -$55.45M 10-Q · filed 2011-11-09 |
| 2011-06-30 | -$50.95M 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |